Novel surfactants with diglutamic acid polar head group: drug solubilization and toxicity studies.
about
Heme oxygenase-1 protects corexit 9500A-induced respiratory epithelial injury across speciesThe use of human umbilical vein endothelial cells (HUVECs) as an in vitro model to assess the toxicity of nanoparticles to endothelium: a review.Nanoparticle self-assembly by a highly stable recombinant spider wrapping silk protein subunit
P2860
Novel surfactants with diglutamic acid polar head group: drug solubilization and toxicity studies.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Novel surfactants with digluta ...... lization and toxicity studies.
@en
Novel surfactants with digluta ...... lization and toxicity studies.
@nl
type
label
Novel surfactants with digluta ...... lization and toxicity studies.
@en
Novel surfactants with digluta ...... lization and toxicity studies.
@nl
prefLabel
Novel surfactants with digluta ...... lization and toxicity studies.
@en
Novel surfactants with digluta ...... lization and toxicity studies.
@nl
P2093
P2860
P50
P1476
Novel surfactants with digluta ...... ilization and toxicity studies
@en
P2093
Claire Gignoux
Cécile Poirier
François Lefoulon
Jean-Manuel Péan
Nathalie Ménard
Thomas Arnauld
P2860
P304
P356
10.1007/S11095-012-0714-8
P577
2012-03-27T00:00:00Z